Company Search:
Advanced Search
Sponsored Links
Clovis Oncology Inc Company Snapshot
Clovis Oncology Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Clovis Oncology Inc with three other companies in this sector in the United States: BioSpecifics Technologies Corp. (2014 sales of $14.08 million of which 100% was Pharmaceutical Products), Chiasma Inc ($13.17 million of which 100% was Pharmaceutical), and Sunwin Stevia International Incorporation ($12.87 million of which 81% was Stevioside).

Sales Analysis.
  Stock Performance Chart for Clovis Oncology Inc
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 65.80
(Figures in U.S. Dollars)
1 Week 4.2%   13 Weeks 12.9%  
4 Weeks 84.2%   52 Weeks 267.2%  
Clovis Oncology Inc Key Data:
  Ticker: CLVS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2014 Sales 13,625,000
(Year Ending Jan 2015).
Employees: 309
  Currency: U.S. Dollars Market Cap: 2,917,095,279
  Fiscal Yr Ends: December Shares Outstanding: 44,332,755
  Share Type: Common Closely Held Shares: 1,721,377
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.